Vividion Therapeutics

Vividion Therapeutics is a San Diego-based clinical-stage biopharmaceutical company that discovers and develops precision small-molecule medicines for previously undruggable disease targets. Its proprietary chemoproteomics platform pairs covalent chemistry with proteome-wide screening to map druggable pockets across the human proteome, driving a pipeline in oncology and immunology (including VVD-214, a WRN helicase inhibitor for MSI-high cancers). Vividion was acquired by Bayer in 2021 and operates as an independent subsidiary. It was surfaced in the API Evangelist network as a portfolio company of SoftBank Vision Fund; this profile has been enriched and carries no public developer or API surface (a corporate/scientific website only).

Vividion Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Health Tech, Biotechnology, Pharmaceuticals, and Drug Discovery.

Vividion Therapeutics’ developer surface includes support, engineering blog, and 5 more developer resources.

🌐 Visit website 📡 Source on GitHub

12.3/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealth TechBiotechnologyPharmaceuticalsDrug DiscoveryOncologyPrecision MedicineChemoproteomics

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 12.3/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 4.2 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/vividion-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 2

Status, limits, changes, and where to get help

Contact

Contact

Support

Support

Commercial 2

Pricing, plans, and the legal terms of use

TermsOfService

TermsOfService

PrivacyPolicy

PrivacyPolicy

Company 2

The organization behind the API

Website

Website

Blog

Blog

Source (apis.yml)

aid: vividion-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/vividion-therapeutics.png
name: Vividion Therapeutics
description: Vividion Therapeutics is a San Diego-based clinical-stage biopharmaceutical company that discovers and develops
  precision small-molecule medicines for previously undruggable disease targets. Its proprietary chemoproteomics platform
  pairs covalent chemistry with proteome-wide screening to map druggable pockets across the human proteome, driving a pipeline
  in oncology and immunology (including VVD-214, a WRN helicase inhibitor for MSI-high cancers). Vividion was acquired by
  Bayer in 2021 and operates as an independent subsidiary. It was surfaced in the API Evangelist network as a portfolio company
  of SoftBank Vision Fund; this profile has been enriched and carries no public developer or API surface (a corporate/scientific
  website only).
url: https://raw.githubusercontent.com/api-evangelist/vividion-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- softbank-vision-fund
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-21'
tags:
- Company
- Health Tech
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Oncology
- Precision Medicine
- Chemoproteomics
apis: []
common:
- type: DomainSecurity
  url: security/vividion-therapeutics-domain-security.yml
- type: Website
  url: https://vividion.com/
- type: Contact
  url: https://vividion.com/contact/
- type: Support
  url: https://vividion.com/contact/
- type: Blog
  url: https://vividion.com/news/
- type: TermsOfService
  url: https://vividion.com/terms-of-use/
- type: PrivacyPolicy
  url: https://vividion.com/privacy-notice/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-21'
  status: minimal
  artifacts_added: 1
  pass: local-v1